Cargando…
Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
High-grade serous ovarian cancer (HGSC) is an aggressive cancer with a worse clinical outcome. Therefore, studies about the prognosis of HGSC may provide therapeutic avenues to improve patient outcomes. Since genome alteration are manifested at the protein level, we integrated protein and mRNA data...
Autores principales: | Xie, Hongyu, Wang, Wenjie, Sun, Fengyu, Deng, Kui, Lu, Xin, Liu, Huijuan, Zhao, Weiwei, Zhang, Yuanyuan, Zhou, Xiaohua, Li, Kang, Hou, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575023/ https://www.ncbi.nlm.nih.gov/pubmed/28852147 http://dx.doi.org/10.1038/s41598-017-10559-9 |
Ejemplares similares
-
Proteome profiling of low grade serous ovarian cancer
por: zadeh fakhar, Haniyeh Bashi, et al.
Publicado: (2019) -
Single‐cell transcriptomes reveal heterogeneity of high‐grade serous ovarian carcinoma
por: Hao, Qian, et al.
Publicado: (2021) -
Immune profiling reveals prognostic genes in high-grade serous ovarian cancer
por: Wu, Yong, et al.
Publicado: (2020) -
Proteomic Discovery of Biomarkers to Predict Prognosis of High-Grade Serous Ovarian Carcinoma
por: Kim, Se Ik, et al.
Publicado: (2020) -
Low-grade Serous Ovarian Carcinoma
por: Ricciardi, Enzo, et al.
Publicado: (2018)